SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A slight decline in the revenue of Rs. 13776.60 millions was seen for the March 2022 quarter as against Rs. 13987.40 millions during year-ago period.Net profit declined -24.44% to Rs. 2212.20 millions from Rs. 2927.80 millions.The Operating Profit of the company witnessed a decrease to 3752.00 millions from 4681.70 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 13776.60 13987.40 -1.51 47070.40 47687.20 -1.29 47070.40 47687.20 -1.29
Other Income 22.90 57.20 -59.97 215.50 273.20 -21.12 215.50 273.20 -21.12
PBIDT 3752.00 4681.70 -19.86 13067.50 15371.90 -14.99 13067.50 15371.90 -14.99
Interest 292.90 210.60 39.08 958.60 659.20 45.42 958.60 659.20 45.42
PBDT 3459.10 4471.10 -22.63 12108.90 14712.70 -17.70 12108.90 14712.70 -17.70
Depreciation 609.40 507.30 20.13 2354.80 1966.40 19.75 2354.80 1966.40 19.75
PBT 2849.70 3963.80 -28.11 9754.10 12746.30 -23.48 9754.10 12746.30 -23.48
TAX 637.50 1036.00 -38.47 2253.20 3185.20 -29.26 2253.20 3185.20 -29.26
Deferred Tax -127.00 -77.40 64.08 -61.00 -164.60 -62.94 -61.00 -164.60 -62.94
PAT 2212.20 2927.80 -24.44 7500.90 9561.10 -21.55 7500.90 9561.10 -21.55
Equity 1074.70 1073.20 0.14 1074.70 1073.20 0.14 1074.70 1073.20 0.14
PBIDTM(%) 27.23 33.47 -18.63 27.76 32.23 -13.88 27.76 32.23 -13.88

Laurus Labs Share Price

1229.45 23.00 (1.91%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×